Home / Market News / $TBPH

$TBPH news and market catalysts

The 2 most recent market catalysts affecting $TBPH, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

2 catalysts 1 high impact 1 bullish 1 bearish Biotechnology
Sep 24, 2026 Corporate Catalyst Bearish Impact 55
BTIG Suspends Neutral Rating on Theravance Biopharma
BTIG has suspended its Neutral rating on Theravance Biopharma. This action indicates that the analyst firm is likely undertaking a review of its investment thesis for TBPH, which c…
Aug 10, 2026 Corporate Catalyst Bullish Impact 92
Theravance Biopharma Q2 Adj. EPS $0.18 Beats $0.05 Estimate, Sales $20.731M Miss $21.600M Estimate
Theravance Biopharma (TBPH) announced Q2 earnings where adjusted EPS dramatically exceeded expectations, turning a loss from the prior year into a profit. This strong EPS performan…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.